Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Journal of Genetic Disorders & Genetic ReportsISSN: 2327-5790
Giuseppe Bifulco Author
Subjects of specialization
Affiliation
Polycystic kidney disease, ; ,ADPKD,Angiography, intracranial aneurysms;
Department of Public Health, Chair of Nephrology, Federico II University of Naples, Italy
Biography
Im giuseppe Department of Public Health, Chair of Nephrology, Federico II University of Naples, Italy,Department of Public Health, Chair of Nephrology, Federico II University of Naples, Italy,Department of Public Health, Chair of Nephrology, Federico II University of Naples, Italy
Publications
Case Report Subscription
Treatment with Agalsidase Alfa during Pregnancy in a Heterozygous Female with Fabry Disease
Author(s): Antonio Pisani, Giuseppe Bifulco, Attilio Di Spiezio Sardo and Eleonora Riccio
Introduction: Enzyme replacement therapy (ERT) is the cornerstone of the treatment of Fabry disease (FD), with either agalsidase alfa or beta. Both preparations have been shown to be safe and effective in patients with FD, but there are very few data on the safety of ERT during pregnancy. Here we report a case of a 22-year-old woman with FD who received ERT with agalsidase alfa during the pregnancy.
Case report: The patient, a 22-year-old woman, was diagnosed with FD three years prior to pregnancy. Because of the presence of pain and proteinuria, she started treatment with agalsidase alfa (0.2 mg/kg every 2 weeks) with a substantial amelioration of the view more»
Social Media
Google Scholars / Researchers Sites
